Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$430,682,816
+$25,904,840 QoQ
Shares Held
7,474,537
+12.0% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#39
of 2,514 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. BMY ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in BMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $430,682,816 | 7,474,537 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $404,777,976 | 6,673,998 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $325,336,896 | 6,031,459 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $269,446,428 | 5,974,422 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $267,562,631 | 5,780,139 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $321,227,245 | 5,266,884 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $290,698,482 | 5,139,648 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $403,300,201 | 7,794,747 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $347,669,841 | 8,371,535 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $318,224,991 | 5,868,062 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $256,134,738 | 4,991,907 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $352,692,296 | 6,076,711 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $394,587,543 | 6,170,251 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $538,323,064 | 7,766,889 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $608,075,701 | 8,451,365 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $517,417,467 | 7,278,344 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $412,978,874 | 5,363,362 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $304,368,874 | 4,167,724 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $213,511,517 | 3,424,403 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $316,676,298 | 5,351,974 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $354,356,804 | 5,303,155 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||